Cite

HARVARD Citation

    Pyziak, K. et al. (2021). Potential of enhancer of zeste homolog 2 inhibitors for the treatment of SWI/SNF mutant cancers and tumor microenvironment modulation. Drug development research. 82 (6), pp. 730-753. [Online]. 
  
Back to record